Literature DB >> 1027725

Studies on the role of suppressor cells in specific unresponsiveness to DNCB.

L Polak.   

Abstract

Lymph nodes--and to a lesser extent spleen cells--from guinea-pigs tolerant to DNCB contact sensitivity, when injected into normal syngeneic guinea-pigs, decrease the ability of the recipients to become sensitized to contact with DNCB. The difference between the complete tolerance transferred by parabiosis with tolerant partners and the partial tolerance induced by transfer of tolerant cells can be explained by the different numbers of cells homing in the recipients. The tolergen does not play any role in the transfer of tolerance.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1027725      PMCID: PMC1445245     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  The transfer of tolerance to DNCB-contact sensitivity in guinea pigs by parabiosis.

Authors:  L Polak
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  B-cell suppression of delayed hypersensitivity reactions.

Authors:  S I Katz; D Parker; J L Turk
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

3.  Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells".

Authors:  P Phanupak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

4.  Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice.

Authors:  M Zembala; G L Asherson
Journal:  Nature       Date:  1973-07-27       Impact factor: 49.962

5.  Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity.

Authors:  L Polak; J L Turk
Journal:  Nature       Date:  1974-06-14       Impact factor: 49.962

6.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

7.  Effects of cyclophosphamide on lymphoid tissues labelled with 5-iodo-2-deoxyuridine- 125 I and 51 Cr.

Authors:  J L Turk; L W Poulter
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

8.  Selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; L W Poulter
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

9.  Epicutaneous induction of hyporeactivity in contact sensitization. Demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene.

Authors:  G Sommer; D Parker; J L Turk
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

10.  Differing mechanisms of tolerance and desensitization to dinitrochlorobenzene in guinea pigs.

Authors:  L Polak; H Geleick
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

View more
  5 in total

1.  Effect of the elimination of suppressor cells on the development of DNCB contact sensitivity in guinea-pig.

Authors:  L Polak; C Rinck
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

2.  Induction of suppressor T cells in delayed-type hypersensitivity to Mycobacterium bovis BCG in low-responder mice.

Authors:  R M Nakamura; T Tokunaga
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

3.  The distribution of antigen in flare up reaction in contact sensitivity to DNCB.

Authors:  S Fukushiro; S Nakagawa; M Gotoh; M Koshizawa; K Tanioku
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

4.  Experimental production of pulmonary granulomas; II. Age dependency and immune modulation of granuloma production.

Authors:  Y Hamamoto; K Kinoshita; K Hashimoto; T Matsushita; K Yasuhira
Journal:  Br J Exp Pathol       Date:  1982-10

5.  Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.

Authors:  K Kato; K Yamamoto
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.